Friday - August 15, 2025
University of Texas's MD Anderson and TransCode Therapeutics Announce Strategic Alliance to Advance RNA Therapies for Oncology
August 03, 2022
HOUSTON, Texas, Aug. 3 (TNSres) -- The University of Texas's MD Anderson Cancer Center issued the following news release on Aug. 2, 2022:

The University of Texas MD Anderson Cancer Center and TransCode Therapeutics, Inc. today announced a strategic alliance to advance TransCode's pipeline of RNA-targeted oncology therapeutic and diagnostic candidates.

Through the alliance, TransCode and MD Anderson scientists will collaborate on preclinical studies to further . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products